AAAAAA
Results: 1-25/52
Authors:
SNOWDEN JA
BROOKS PM
MILLIKEN ST
FULLER A
PASSUELLO F
RENWICK J
BIGGS JC
Citation: Ja. Snowden et al., HEMATOPOIETIC STEM-CELL (HSC) MOBILIZATION WITH FILGRASTIM IN SEVERE ACTIVE RHEUMATOID-ARTHRITIS (RA), Bone marrow transplantation, 21, 1998, pp. 180-180
Authors:
SNOWDEN JA
MILLIKEN ST
BROOKS PM
BIGGS JC
Citation: Ja. Snowden et al., HIGH-DOSE CYCLOPHOSPHAMIDE (CY) WITH AUTOLOGOUS STEM-CELL RESCUE IN SEVERE ACTIVE RHEUMATOID-ARTHRITIS (RA) - A DOSE-ESCALATION STUDY, Bone marrow transplantation, 21, 1998, pp. 184-184
Authors:
BRANDON CI
BARBER MR
BROOKS PM
FAYRERHOSKEN RA
Citation: Ci. Brandon et al., CANINE IMMUNOSTERILIZATION WITH A PORCINE ZONA-PELLUCIDA VACCINE, Theriogenology, 49(1), 1998, pp. 262-262
Authors:
MARCH LM
BRNABIC AJM
SKINNER JC
SCHWARZ JM
FINNEGAN T
DRUCE J
BROOKS PM
Citation: Lm. March et al., MUSCULOSKELETAL DISABILITY AMONG ELDERLY PEOPLE IN THE COMMUNITY, Medical journal of Australia, 168(9), 1998, pp. 439-442
Authors:
BROOKS PM
KELLETT B
Citation: Pm. Brooks et B. Kellett, COPPER-SALICYLATE GEL FOR PAIN RELIEF IN OSTEOARTHRITIS, Medical journal of Australia, 168(6), 1998, pp. 312-312
Authors:
BROOKS PM
GOULSTON KJ
Citation: Pm. Brooks et Kj. Goulston, FUTURE OF MEDICAL-TRAINING IN AUSTRALIA, Medical journal of Australia, 168(10), 1998, pp. 504-505
Authors:
SNOWDEN JA
MILLIKEN ST
BROOKS PM
BIGGS JC
Citation: Ja. Snowden et al., AUTOGRAFTING IN SEVERE ACTIVE RHEUMATOID-ARTHRITIS (RA) - MOBILIZATION AND DOSE-ESCALATION STUDIES, British Journal of Haematology, 101, 1998, pp. 191-191
Authors:
BROOKS PM
SNOWDEN J
BIGGS J
MILLIKIN S
Citation: Pm. Brooks et al., A PILOT DOSE-ESCALATION OF HIGH-DOSE CYCLOPHOSPHAMIDE (CY) AND AUTOLOGOUS STEM-CELL THERAPY (ASCT) IN ACTIVE RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 598-598
Authors:
SNOWDEN JA
KEARNEY P
KEARNEY A
COOLEY HM
GRIGG A
JACOBS P
BERGMAN J
BROOKS PM
BIGGS JC
Citation: Ja. Snowden et al., LONG-TERM OUTCOME OF AUTOIMMUNE-DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Arthritis and rheumatism, 41(3), 1998, pp. 453-459
Authors:
JAMAL OS
CONAGHAN PG
CUNNINGHAM AM
BROOKS PM
MUNRO VF
SCOTT KF
Citation: Os. Jamal et al., INCREASED EXPRESSION OF HUMAN TYPE IIA SECRETORY PHOSPHOLIPASE A(2) ANTIGEN IN ARTHRITIC SYNOVIUM, Annals of the Rheumatic Diseases, 57(9), 1998, pp. 550-558
Authors:
BOERS M
TUGWELL P
BROOKS PM
Citation: M. Boers et al., PROGRESS TOWARDS OPTIMAL TRIAL END-POINTS IN RHEUMATOID-ARTHRITIS, Biodrugs, 7(1), 1997, pp. 40-50
Authors:
MCFARLANE AC
BROOKS PM
Citation: Ac. Mcfarlane et Pm. Brooks, THE ASSESSMENT OF DISABILITY AND HANDICAP IN MUSCULOSKELETAL DISEASE, Journal of rheumatology, 24(5), 1997, pp. 985-989
Authors:
BROOKS PM
Citation: Pm. Brooks, HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASES, Journal of rheumatology, 24, 1997, pp. 19-22
Authors:
BAGGE E
TRAUB M
CROTTY M
CONAGHAN PG
OH E
BROOKS PM
Citation: E. Bagge et al., ARE RHEUMATOID-ARTHRITIS PATIENTS MORE WILLING TO ACCEPT NONSTEROIDALANTIINFLAMMATORY DRUG-TREATMENT RISKS THAN OSTEOARTHRITIS PATIENTS, British journal of rheumatology, 36(4), 1997, pp. 470-472
Authors:
CONAGHAN PG
CROTTY M
OH E
DAY RO
BROOKS PM
Citation: Pg. Conaghan et al., ANTIRHEUMATIC DRUG-PRESCRIBING BEHAVIOR OF AUSTRALASIAN RHEUMATOLOGISTS 1984-1994, British journal of rheumatology, 36(4), 1997, pp. 487-490
Authors:
MCGILL P
ADEBAJO A
NJOBVU PD
BROOKS PM
Citation: P. Mcgill et al., TROPICAL RHEUMATOLOGY - CHALLENGE OF THE FUTURE, British journal of rheumatology, 36(3), 1997, pp. 307-309
Authors:
SHACKEL NA
DAY RO
KELLETT B
BROOKS PM
Citation: Na. Shackel et al., COPPER-SALICYLATE GEL FOR PAIN RELIEF IN OSTEOARTHRITIS - A RANDOMIZED CONTROLLED TRIAL, Medical journal of Australia, 167(3), 1997, pp. 134-136
Authors:
LEHMANN T
DAY RO
BROOKS PM
Citation: T. Lehmann et al., RHEUMATOLOGY .12. TOXICITY OF ANTIRHEUMATIC DRUGS, Medical journal of Australia, 166(7), 1997, pp. 378-383
Authors:
SNOWDEN JA
BROOKS PM
BIGGS JC
Citation: Ja. Snowden et al., HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASES, British Journal of Haematology, 99(1), 1997, pp. 9-22
Authors:
BROOKS PM
BACHMEIER CJM
MARCH LM
CROSS M
COURTENAY B
SCHWARZ J
COOLICAN M
RUFF S
CROSS MJ
LAPSLEY H
Citation: Pm. Brooks et al., A COMPARISON OF WOMAC AND MOS SF-36 IN OA PATIENTS UNDERGOING JOINT REPLACEMENT, Arthritis and rheumatism, 40(9), 1997, pp. 479-479
Authors:
JAMAL OS
CONAGHAN PG
BROOKS PM
MUNRO VF
SCOTT KF
Citation: Os. Jamal et al., ENHANCED EXPRESSION OF HUMAN TYPE-II SECRETORY PHOSPHOLIPASE A(2) IN ARTHRITIC SYNOVIUM, Arthritis and rheumatism, 40(9), 1997, pp. 1315-1315
Authors:
BROOKS PM
Citation: Pm. Brooks, UNDERGRADUATE EDUCATION IN RHEUMATOLOGY, British journal of rheumatology, 35(3), 1996, pp. 203-204
Authors:
JONES G
BROOKS PM
Citation: G. Jones et Pm. Brooks, INJECTABLE GOLD COMPOUNDS - AN OVERVIEW, British journal of rheumatology, 35(11), 1996, pp. 1154-1158
Authors:
SNOWDEN JA
BIGGS JC
BROOKS PM
Citation: Ja. Snowden et al., AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASES, Lancet, 348(9035), 1996, pp. 1112-1113
Authors:
BROOKS PM
Citation: Pm. Brooks, MJA PRACTICE ESSENTIALS - RHEUMATOLOGY - A TEMPLATE FOR DIAGNOSIS ANDMANAGEMENT OF MUSCULOSKELETAL DISEASES, Medical journal of Australia, 165(6), 1996, pp. 331-331